Table 1

Clinical and sociodemographic data (Nā€‰=ā€‰242)
Frequency (%)
Age Median (SD) 65.00 y (8.3y)
Range 40-84y
Marital status Single 18 (8.4%)
Partnership, marriage 135 (63.1%)
Divorced, separated 28 (13.1%)
Widowed 33 (15.4%)
Employment status Full-time 16 (7.5%)
Part-time 16 (7.5%)
Unemployed 5 (2.1%)
Homemaker 31 (14.5%)
Retired 142 (66.4%)
Other 4 (1.6%)
Histological classification Invasive 226 (93.4%)
In situ 15 (6.2%)
Missing 1 (0.4%)
Grading Grade I 35 (14.5%)
Grade II 176 (72.7%)
Grade III 10 (4.1%)
Unknown 21 (8.7%)
Duration of adjuvant endocrine therapy (months) Median (SD) 26.7 (19.1) mo.
Range 0.7- 89.5 mo.
Primary surgical treatment Breast-conserving procedure 155 (65.7%)
Mastectomy 81 (34.3%)
Reconstruction 43 (18.2%)
Chemotherapy 41 (16.9%)
Radiotherapy 169 (71.3%)

Oberguggenberger et al.

Oberguggenberger et al. BMC Cancer 2012 12:474   doi:10.1186/1471-2407-12-474

Open Data